Detection of intestinal colonization by carbapenem-resistant Enterobacteriaceae (CRE) among patients admitted to a tertiary care hospital in Egypt

Bibliographic Information
Authors: El-Defrawy I.; Gamal D.; El-Gharbawy R.; El-Seidi E.; El-Dabaa E.; Eissa S.
Journal: Egyptian Journal of Medical Human Genetics
Publisher: Springer Science and Business Media Deutschland GmbH
Publication Date: 19 April 2022
Volume / Issue: Volume 23 / Issue 1
Article No.: 83
ISSN: 11108630
DOI: 10.1186/s43042-022-00295-9
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
El-Defrawy I., Microbiology Department, Theodor Bilharz Research Institute (TBRI), PM Box 30 Imbaba, Giza, Egypt; Gamal D., Microbiology Department, Theodor Bilharz Research Institute (TBRI), PM Box 30 Imbaba, Giza, Egypt; El-Gharbawy R., Microbiology Department, Theodor Bilharz Research Institute (TBRI), PM Box 30 Imbaba, Giza, Egypt; El-Seidi E., Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University, Giza, Egypt, Galala University, Suez, Egypt; El-Dabaa E., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), PM Box 30, Imbaba, Giza, Egypt; Eissa S., Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University, Giza, Egypt
Abstract
Background: The irrational use of carbapenems in the last years lead to the emergence of carbapenem-resistant Enterobacteriaceae (CRE). This study aimed at determining the prevalence of CRE intestinal carriage among admitted patients in a tertiary care hospital in Egypt, to characterize carbapenemase-producing genes and to identify possible risk factors of CRE colonization. One hundred rectal swabs were collected from patients within 48 h of hospital admission. Culture was done on chromogenic media and then identification and antibiotic susceptibility testing were done using Vitek 2 compact system. Carbapenemase production was confirmed by Rapidec Carba NP test and by multiplex PCR for blaOXA-48-like, blaNDM-like, blaVIM-like, blaIMP-like and blaKPC-like. Results: A total number of 36 CRE isolates were recovered from 28 patients. Thus, the prevalence of CRE colonization was 28%. Escherichia coli (83%), followed by Klebsiella pneumoniae (17%) were the main species. History of recent hospitalization and prior antibiotic intake were statistically significant risk factors predisposing to CRE colonization. Rapidec Carba NP gave positive results in 29/36 CRE isolates, whereas seven isolates gave negative results; six of them harbored blaOXA-48-like. Overall, the blaOXA-48-like was detected in 24/36 (66.7%), followed by blaNDM-like in 11/36 (30.6%) and lastly blaVIM-like in 1/36 (2.8%). Conclusions: Our findings confirm that CRE colonization is disseminating in our healthcare facility, a fact that should be considered as possible pathogens causing infections in high risk patients. Strict infection control measures should be applied to all CRE carriers at hospital admission and a proper antimicrobial stewardship program should be followed in clinical settings. © 2022, The Author(s).
Keywords
Carbapenemases; Colonization; CRE; Enterobacteriaceae; NDM; OXA-48; amikacin; ampicillin; aztreonam; carbapenem derivative; cefazolin; cefepime; ceftriaxone; ciprofloxacin; cotrimoxazole; ertapenem; gentamicin; imipenem; meropenem; moxifloxacin; nitrofurantoin; sultamicillin; tigecycline; tobramycin; adult; antibiotic sensitivity; antimicrobial stewardship; Article; bacterial colonization; bacterium detection; carbapenem-resistant Enterobacteriaceae; carbapenemase producing Enterobacteriaceae; clinical laboratory standard; comorbidity; controlled study; Egypt; Escherichia coli; female; health care facility; high risk patient; hospital admission; hospital patient; human; infection control; inhibitory concentration; intestine infection; Klebsiella pneumoniae; major clinical study; male; minimum inhibitory concentration; multiplex polymerase chain reaction; nonhuman; rectal swab; risk factor; tertiary care center
Citation Information
Scopus Citations: 11
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
